Applied Cells MARS Ingenuity

New cell isolation reagent kits offer streamlined workflow for cell therapy development

Applied Cells has launched the ‘MARS Ingenuity’ line of immunomagnetic cell isolation reagent kits designed to work seamlessly with their proprietary MARS Bar platform. These kits contain biodegradable superparamagnetic beads conjugated with monoclonal antibodies for positive selection of specific cell types like CD4+, CD8+, CD14+, and CD3/28+ cells.  

Bio Rad UnityNext

Bio-Rad launches Unity Next Peer QC data management software in EMEA

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics products, has launched its Unity Next Peer QC  https://tinyurl.com/yrtu7x6b  data management software in Europe, the Middle East, and Africa. This software is designed to help troubleshoot Quality Control failures and increase confidence in patient testing results.

Thermo Fisher ULTFreezer

Thermo Fisher Scientific unveils new TSX Universal Series ULT Freezers

Building on 80 years of expertise engineering cold storage lab equipment, Thermo Fisher Scientific has unveiled its newest line of high performance, ultra-low temperature (ULT) freezers. With enhancements to performance, user experience and energy efficiency, the Thermo Scientific TSX Universal Series ULT Freezers seamlessly adapt to scientists’ workflows across a variety of lab settings, marking […]

Azenta Ziath 48 tube picker

Ziath Mohawk 48-position tube picker boosts lab efficiency

The 48-position Ziath Mohawk tube picker from Azenta Life Sciences selects and picks wide, heavy, or tall tubes making this system perfect for retrieving individual whole tissue samples from storage.

bio rad ddPLEX ESR1

Bio-Rad unveils first ultrasensitive multiplexed digital PCR assay for breast cancer mutation detection

Bio-Rad Laboratories, a global leader in life science research and clinical diagnostic products, has introduced its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. The assay expands the company’s Droplet Digital PCR (ddPCR) offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, […]

shutterstock 209715799

WHO renews partnership with UK Collaborating Centre to facilitate biosafety training globally

In the wake of recent global outbreaks, people around the world were alerted to the importance of proper biosafety precautions, and the role they can play in stopping public health catastrophes.

Sartorius Incucyte

Sartorius and TheWell Bioscience collaboration to advance production of 3D cell models

The life science group Sartorius and US-based start-up TheWell Bioscience will collaborate on the further development of hydrogels and bioinks tailored to produce 3D advanced cell models for drug discovery workflows. In addition to this, Sartorius will expand the portfolio of its lab division by distributing TheWell Bioscience’s products and invest in a minority shareholding […]

ProteoNic

ProteoNic unveils Early Access Program: Elevating viral vector titers with transformative LV-2G UNic technology

ProteoNic Biosciences, a leading provider of premium vector technology and services for the production of biologics, has launched its highly anticipated LV-2G UNic Early Access Program. This programme marks a significant milestone in lentivirus manufacturing optimization, offering access to groundbreaking vector technology designed to revolutionize viral vector production.

Olink Signature

Synexa Life Sciences expands biomarker discovery capabilities with the addition of Olink Target Platform

Synexa Life Sciences, a global Clinical Laboratory Services provider for the biopharma industry, has integrated the Olink Target immunoassays and the Olink Signature Q100 instrument into its extensive suite of biomarker discovery platforms.

Ivor Campbell

Could Amazon or Google hold the key to the future of public health diagnostics?

Anyone who works in medical technology knows that the industry is currently focused obsessively on two prime targets – maximising the availability of self-testing and playing its part in the common goal to achieve net zero.